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Abstract
Glutathione reductase (GR) is a chemotherapeutic target. Murine GRcDNA, which contains 85% GC in the 38 codons
following the start codon, was assembled from the PCR-amplified exon 1 and a downstream cDNA prior to expression in
Escherichia coli as a His6-tagged protein. Recombinant GR, an FAD-containing homodimer, corresponds in its enzymic and
spectral properties to GR isolated from murine Ehrlich ascites tumor cells. Another cDNA, representing GR with a
mitochondrial targeting sequence, yielded two distinct enzymically active expression products. ß 2000 Elsevier Science
B.V. All rights reserved.
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Glutathione reductase (GR, EC 1.6.4.2) is an anti-
oxidant dimeric £avoenzyme of approximately 105
kDa which catalyses the reaction NADPH+gluta-
thione disul¢de+HCNADP+2 glutathione-SH
[1,2].
Murine GR has been used for in vivo or ex vivo
studies, for instance, for mapping the distribution of
the enzyme in the brain, especially in dopaminergic
regions [3], for studying the e¡ects of carmustine on
glioblastoma and other brain tumors, and as a puta-
tive target of the chemotherapeutic nitrosourea HeC-
NU in murine malaria [2,4]. As a prerequisite for
genetic, biochemical and pharmacological experi-
ments on mouse GR we studied the cDNA encoding
this enzyme.
In most human and murine cells, especially in fast-
growing cells, the GR gene is highly expressed [5^7].
Indeed, in proliferating human lymphocytes
GRmRNA represents a predominant message [6].
Screening of various murine cDNA libraries with
GR-speci¢c probes yielded as many as 48 positives.
None of these clones, however, included a 5P-end
sequence [5,8] nor have these sequences so far been
generated as expressed sequence tags (ESTs) of any
human or murine tissue.
As reported here, PCR ampli¢cation of the 5P-end
of the coding sequence was achieved using murine
genomic DNA and primers ¢tting the exon 1 se-
quence published by Tamura et al. [9]. For PCR,
the recently introduced GC-RICH PCR system
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(Roche Molecular Biochemicals) was successfully ap-
plied, the resolution solution having a ¢nal concen-
tration of 1 M. Other PCR systems failed to give any
ampli¢cation signal. These observations suggest that
it is the high GC content of 85% at the 5P-end of the
coding region [9,10] which has been the major ob-
stacle to cloning this segment in the past [5^9]. It is
also conceivable that the missing 5P-ends of
GRcDNAs, and possibly of other cDNAs, in EST
libraries are due to GC rich sequences.
The ampli¢ed exon 1 sequence was fused at the
common SacII site with the downstream sequence
of murine GRcDNA which had previously been
cloned [5,8,10]. As shown by automated sequencing,
the coding section of murine GRcDNA was found to
be 100% identical with the sequence of exon 1 to
exon 13 in the GR gene of the mouse strain
SVJ129 [9]. Accordingly, the deduced partial amino
acid sequence reported earlier [8] had to be revised at
positions 39^43 and 59 (Fig. 1 and [10]).
The deduced amino acid sequence of mouse GR
aligned with human GR is given in Fig. 1. As shown
by Tamura et al. [9], residues 1^26 of murine GR
represent a mitochondrial targeting sequence
(MTS); the mature form of the enzyme, functioning
in the cytosol and in the mitochondrial matrix, prob-
ably starts at or around Met-27. By inference from
the known structure of human GR [11], the actually
Fig. 1. Deduced amino acid sequences of murine glutathione reductase in comparison with human glutathione reductase. The aligned
sequences as shown here contain no deletion or insertion. An alternative alignment of the £exible section of the proteins (located N-
terminally to Val-18 of human GR and to Thr-40 of murine GR) superimposes Met-27 of murine GR with the initiator Met (M) of
the human enzyme [9]. In this alternative alignment, a deletion corresponding to a pentapeptide precedes Thr-40 in the murine GR se-
quence.
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folded protein begins with the FAD-binding domain
of the enzyme, that is, with Thr-40 in murine GR,
Val-18 in human GR and Thr-3 in Escherichia coli
GR. When comparing the compact domains com-
prising residues 40^500 of murine GR with the
equivalent structure of human GR (residues 18^
478), we ¢nd 88% identities (Fig. 1). According to
model building based on the structure of human GR,
the amino acid exchanges are located at the surface
of the proteins. The residues with assigned function
[1,11,12] are conserved between the glutathione re-
ductases from man and mouse.
For studying functional expression of GRcDNA,
the coding region (residues 1^500), including and ex-
cluding the mitochondrial targeting sequence (MTS)
was recloned in the pQE-30 vector using KpnI and
HindIII as restriction enzymes. High expression of
the recombinant protein was achieved in E. coli
M15 cells (Qiagen).
Both expressed proteins, GRMTS and GR, contain
two sequences of the expression vector, namely the
C-terminal extension VDLEPSLIS as a cloning relic
and an N-terminal His6-tag of 18 amino acids,
namely MRGSHHHHHHGSACELGT. This pep-
Table 1
Puri¢cation of authentic mouse GR from EAT cells
Fraction Volume
(ml)
Activity
(U)
Protein
(mg)
Speci¢c activity
(U/mg)
Puri¢cation
(fold)
EAT cell pellet 58 242 3660 0.066 1
Chloroform/butanol extract 81 190 1650 0.12 1.7
Extract of acetone precipitate 85 158 1000 0.16 2.4
2P,5P-ADP Sepharose eluate 0.5 117 1.25 93.6 1420
Pooled GR after 80‡C treatment 0.2 82 0.49 167 2530
The cells were extracted in the presence of chloroform-butanol as previously described [14,15]. The extract was precipitated with ace-
tone (50% ¢nal concentration), and the precipitate was extracted with a small volume of bu¡er F containing 5 WM FAD. Bu¡er F is
1 mM dithiothreitol, 1 mM EDTA, 20 mM potassium phosphate, pH 7.5. After dialysis and centrifugation, the protein solution was
applied at room temperature to a 5-ml column of 2P,5P-ADP Sepharose equilibrated with bu¡er F. The column was washed with 4 vol.
of bu¡er F, 3 vol. of 250 mM KCl in this bu¡er, 1.5 vol. of 500 mM KCl in bu¡er F and 3 vol. DTE-free bu¡er F. GR was eluted
with 1 mM NADPH in DTE-free bu¡er. The eluate was then adjusted to the conditions needed for the ensuing heat step (10^20 U/
ml mGR, 5 mM GSSG, 5 WM FAD in 50 mM potassium phosphate of pH 7.0). This solution was kept at 80‡C for 10^15 min and
subsequently at 0‡C for 2 h. After a clearing spin, the protein was concentrated by Centriprep 30 to a ¢nal concentration of 1 mg/ml
in bu¡er F and stored at 4‡C. Alternatively, the enzyme was prepared along with thioredoxin reductase according to Gromer et al.
[15]. Care was taken that all GR-containing fractions from the DEAE cellulose-column were applied to the 2P,5P-ADP Sepharose col-
umn.
Table 2
Characteristics of recombinant mouse glutathione reductase compared with the enzyme isolated from murine EAT cells (see Table 1)
and liver [17].
Recombinant tagged GR Recombinant tagged GRMTS GR from EAT cells GR from liver [17]
Subunit Mr
With tags 54 720 57 380
Without tags 51 800 54 460 52 050 [14] 52 500
Km of GSSG 95 WM n.d. 79 WM 107 WM
Km of NADPH 7.3 WM n.d. 6.9 WM 5.9 WM
kcat (min31) 7000^8500 1400^2000 7500^10 300 8300
O280 nm (mM31 cm31) 68.1 68.1 68.1 62.1a
O463 nm (mM31 cm31) 11.3 11.3 n.d. 9.11a
Unless otherwise stated, the data were obtained in this study. The pure murine enzyme has an absorption coe⁄cient of 68.1 mM31
cm31 at 280 nm. This value was computed on the basis of the O-value of human GR (70.7 mM31 cm31) by taking into account that
mouse GR contains two Tyr residues less (see Fig. 1).
aThe mouse liver GR preparation appears to have contained approximately 20% FAD-free apoenzyme.
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tide chelates transition element-ions and thus allows
puri¢cation of the proteins on NiNTA-agarose ac-
cording to the instructions of the manufacturer (Qia-
gen).
In short, 1.5 g transformed and induced E. coli
M15 cells was lysed and extracted as detailed by
Nordho¡ et al. [13], but an EDTA-free bu¡er was
used (bu¡er E, 50 mM sodium phosphate, 300 mM
NaCl, pH 8.0). After a clearing centrifugation, the
supernatant was assayed for glutathione reductase
activity [2,13], and 1400 enzyme units in 30 ml ex-
tract were applied to a 3-ml NiNTA column equili-
brated with the same bu¡er. The column was washed
with 4 vol. 10 mM imidazole in bu¡er E and then by
2 vol. 25 mM imidazole, 2 vol. 50 mM imidazole,
and 50 mM imidazole/10% glycerol, all in bu¡er E.
Subsequently, the enzyme was eluted with 100 mM
imidazole in bu¡er E in a total volume of 3 ml. The
overall yield was 4 mg s 99% pure enzyme with a
speci¢c activity of 160 U/mg which corresponds to a
turnover number of 8540/min. Protein concentration
was determined using the O-values given in Table 2.
In an analogous fashion, we expressed and puri¢ed
the cDNA encoding tagged GRMTS which contains
the nickel-chelating peptide followed by the mito-
chondrial targeting sequence. However, in this case,
the enzyme activity was eluted in two peaks from the
NiNTA-agarose column, one at 25 mM imidazole in
bu¡er E and one at 100 mM imidazole in bu¡er E.
The latter peak yielded 1.5 mg pure His6-tagged
GRMTS with a speci¢c activity of 30 U/mg. This re-
producibly low speci¢c activity indicates that the tar-
geting sequence and the mature portion of the pre-
cursor protein in£uence each other [16]. The ¢rst
peak, eluted together with numerous contaminants
at 25 mM imidazole, was puri¢ed to homogeneity
by applying the eluate directly to a 2-ml 2P,5P-ADP
Sepharose column and developing this column ac-
cording to a protocol described below (see legend
of Table 1). We assume that this enzyme species of
105 U/mg represents recombinant murine GR whose
MTS and thus its His6-tag were cleaved by an E. coli
protease. Alternatively, it might represent an enzyme
species whose synthesis started at Met-27 [9].
In order to compare the recombinant mouse GR
with the authentic enzyme from murine Ehrlich as-
cites tumor (EAT) cells, the latter protein was puri-
¢ed as described in Table 1.
The properties of recombinant GR are summar-
ized in Table 2. The protein has a calculated Mr of
54 720 per subunit representing the N-terminal nick-
el-chelating peptide of 1970 Da, the C-terminal ex-
tension of 950 Da, and the actual FAD-containing
protein subunit of 51 800. As shown by gel ¢ltration
the functional enzyme is a dimer. The Ni2-chelating
peptide appears not to change the properties of the
enzyme since the kinetic parameters of recombinant
His6-tagged GR are in good agreement with the data
determined for the enzyme from liver [17] and from
EAT cells ([14] and Table 2). As shown in Fig. 2 the
major intermediates of the catalytic cycle of gluta-
thione reductase [1,18] can be made visible by £avin
spectroscopy of the recombinant enzyme. The issue
of murine glutathione reductase allelozymes with
very similar properties [14,19] is not addressed in
this paper.
The functional characterization of the recombinant
enzyme as a glutathione reductase veri¢es that the
sequence of the recombinant protein represents mur-
ine glutathione reductase. This veri¢cation is neces-
Fig. 2. Flavin spectra of murine recombinant tagged GR. The
measurements were conducted aerobically with 31 WM enzyme
subunit in 1000 Wl GR assay bu¡er [2,18] at 25‡C. The four
spectra represent intermediates of the catalytic cycle. The ex-
periment started out with Eox, the yellow oxidized enzyme spe-
cies. EH2, the 2-electron reduced orange-colored enzyme spe-
cies, was obtained from Eox within 10 min using 400 WM
dithiothreitol. The spectrum of the NADPH-EH2 complex was
then produced by adding 25 Wl 4 mM NADPH to 1 ml EH2.
The intensi¢cation of the thiolate-FAD charge-transfer observed
at 540 nm appeared within the dead time of the instrument.
Subsequently, the enzyme was reoxidized to EPox using 50 Wl
20 mM GSSG. The spectra of Eox and EPox di¡er because the
substrate additions lead to dilution. Vvis;max was found to be
463 nm and 450 nm for Eox and EH2, respectively.
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sary since disul¢de reductases with other disul¢de
substrate speci¢cities [1,15,20] have similar sequences
which means that they are often listed as ‘glutathione
reductases’ in sequence data bases.
The pharmacologic characterization of murine
glutathione reductase can now be con¢rmed and
extended by biochemical studies on the isolated
recombinant protein. The sequence comparison
shown in Fig. 1 indicates that mouse GR is indeed
a good model of human GR in biomedical studies.
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